{
    "2020-02-20": [
        [
            {
                "time": "",
                "original_text": "大金融掀起涨停潮  牛市开启了？",
                "features": {
                    "keywords": [
                        "大金融",
                        "涨停潮",
                        "牛市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "一大批药企将迎来集中收获期",
                "features": {
                    "keywords": [
                        "药企",
                        "收获期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行情恢复理性  机构建议关注长期向好的核心资产",
                "features": {
                    "keywords": [
                        "医药行情",
                        "理性",
                        "核心资产"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "专注肿瘤的免疫治疗产品研发的宜明昂科获4500万元Pre-B轮融资",
                "features": {
                    "keywords": [
                        "肿瘤",
                        "免疫治疗",
                        "宜明昂科",
                        "融资"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}